Publication Products
| Chemical Structure | Cat. No. | Product Name | CAS No. |
|---|
 |
BCP27641 | Cabazitaxel Hot | 183133-96-2 |
A novel semi-synthetic taxane with antitumor activity used for the treatment of castration-resistant prostate cancer. A microtubule inhibitor.
|
|||
 |
BCP21111 | PA-824 | 187235-37-6 |
PA-824 is an experimental anti-tuberculosis drug and one of two nitroimidazoles in phase II clinical trials to treat tuberculosis.
|
|||
 |
BCP20310 | Infliximab | 170277-31-3 |
Infliximab is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α) and is used to treat autoimmune diseases.
|
|||
 |
BCP01984 | SU-6668 | 252916-29-3 |
TSU-68 (SU6668)is a novel multiple receptor tyrosine kinase inhibitor with IC50 of 2.1 μM, 8 nM and 1.2 μM for VEGF-R1, PDGF-Rβ and FGF-R1, respectively.
|
|||
 |
BCP30527 | Trastuzumab emtansine New | 1018448-65-1 |
Trastuzumab emtansine is an antibody-drug conjugate (ADC), a combination between a monoclonal antibody and a small-molecule drug. Each molecule of trastuzumab emtansine consists of a single trastuzumab molecule with several molecules of DM1, a cytotoxic maytansinoid, attached.
|
|||
 |
BCP07008 | Wnt-C59 | 1243243-89-1 |
Wnt-C59 (C59) is a PORCN inhibitor for Wnt3A-mediated activation of a multimerized TCF-binding site driving luciferase with IC50 of 74 pM.
|
|||
 |
BCP13190 | BMS 777607 New | 1196681-44-3 |
BMS 777607 is a novel, selective and orally available ATP-competitive MET kinase inhibitor that primarily targets several MET family members, including RON, MET, Tyro-3 and AxI, with half maximal inhibitory concentration IC50 of 1.8 nmol/L, 3.9 nmol/L, 4.3 nmol/L and 1.1 nmol/L respectively.
|
|||
 |
BCP06831 | Argatroban | 74863-84-6 |
Argatroban is a direct, selective thrombin inhibitor.
|
|||
 |
BCP02337 | Plerixafor | 110078-46-1 |
Plerixafor (AMD3100) is a chemokine receptor antagonist for CXCR4 and CXCL12-mediated chemotaxis with IC50 of 44 nM and 5.7 nM, respectively.
|
|||
 |
BCP01404 | Rapamycin New | 53123-88-9 |
Rapamycin is antifungal and immunosuppressant and specific inhibitor of mTOR.
|
|||
 |
BCP02227 | WYE-125132 | 1144068-46-1 |
WYE-125132 is a highly potent, ATP-competitive and specific mTOR kinase inhibitor with an IC50 of 0.19 nM.
|
|||
 |
BCP02171 | AZD8055 | 1009298-09-2 |
AZD-8055 is a potent, selective, and orally bioavailable ATP-competitive mTOR kinase inhibitor with an IC50 of 0.8 nM.
|
|||
 |
BCP07817 | Conivaptan | 210101-16-9 |
Conivaptan is a nonpeptide dual V1a/V2 AVP receptor antagonist.
|
|||
 |
BCP07266 | Talazoparib New | 1207456-01-6 |
Talazoparib (BMN-673) is a highly potent PARP1/2 inhibitor with Kis of 1.2 nM and 0.87 nM, respectively.
|
|||
 |
BCP31225 | Chloral hydrate New | 302-17-0 |
Chloral hydrate is a mild hypnotic that is used to treat simple insomnia. Despite many years of use, chloral hydrate has not been implicated in causing serum enzyme elevations or clinically apparent liver injury.
|
|||
 |
BCP15902 | GRGDNP | 114681-65-1 |
RGD peptide is a synthetic compound made up of the arginine-glycine-aspartate motif that has been extensively used to inhibit integrin-ligand interactions in studies related to cell adhesion， migration， growth， and differentiation.
|
|||
 |
BCP02829 | Bedaquiline New Discount | 843663-66-1 |
Bedaquiline, also known as TMC207 and R207910, is a diarylquinoline anti-tuberculosis drug.
|
|||
 |
BCP07792 | Clofazimine New | 2030-63-9 |
Clofazimine is a fat-soluble iminophenazine dye, has a marked anti-inflammatory effect, has been used in combination with other antimycobacterial drugs to treat AIDS and Crohn's disease.
|
|||
 |
BCP01714 | GDC-0941 | 957054-30-7 |
GDC-0941 is a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer.
|
|||
 |
BCP01923 | PI-103 | 371935-74-9 |
PI-103 is inhibitor of DNA-PK, PI 3-kinase (p110α) and mTOR.
|
|||
